Investors Alert: Intrexon Corporation (NYSE:XON), Array BioPharma Inc. (NASDAQ:ARRY), United Security Bancshares Inc. (NASDAQ:USBI), Innospec Inc. (NASDAQ:IOSP),

Intrexon Corp. (NYSE:XON) on Monday reported a fourth-quarter loss of $32.7 million, after reporting a profit in the same period a year earlier. On a per-share basis, the Germantown, Maryland-based company said it had a loss of 28 cents. Losses, adjusted for non-recurring costs, came to 17 cents per share. The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.

Intrexon Corporation (NYSE:XON) belongs to Healthcare sector. Its net profit margin is -20.20% and weekly performance is -5.29%. On last trading day company shares ended up at $30.95. Intrexon Corporation (NYSE:XON) distance from 50-day simple moving average (SMA50) is 3.97%.

Zacks Investment Research downgraded shares of Array Biopharma Inc (NASDAQ:ARRY) from a buy rating to a hold rating in a research report published on Thursday.

Array BioPharma Inc. (NASDAQ:ARRY) shares fell -3.46% in last trading session and ended the day at $2.51. ARRY Gross Margin is 56.00% and its return on assets is 0.20%. Array BioPharma Inc. (NASDAQ:ARRY) quarterly performance is -37.25%.

United Security Bancshares, Inc. (NASDAQ:USBI) announced that the Board of Directors, at a meeting held on February 24, 2016, declared a quarterly cash dividend of $0.02 per share. The dividend is payable April 1, 2016, to shareholders of record at the close of business on March 11, 2016.

On 29 February, United Security Bancshares Inc. (NASDAQ:USBI) shares increased 0.12% and was closed at $8.29. USBI EPS growth in last 5 year was 22.60%. United Security Bancshares Inc. (NASDAQ:USBI) year to date (YTD) performance is -7.06%.

On 16 February, Innospec Inc. (NASDAQ:IOSP) announced its financial results for the fourth quarter and full year ended December 31, 2015. Total net sales for the fourth quarter were $246.0 million, a 15 percent decrease from $290.7 million in the corresponding period last year. For the full year, sales reached a record $1.0 billion, up 5 percent on 2014.

Innospec Inc. (NASDAQ:IOSP) ended the last trading day at $43.40. Company weekly volatility is calculated as 3.90% and price to cash ratio as 7.35. Innospec Inc. (NASDAQ:IOSP) showed a weekly performance of -0.37%.

LogMeIn, Inc.’s (NASDAQ:LOGM) has been named a “market disruptor” by Frost & Sullivan in their 2015 Analysis of the Global Web Conferencing market. The report looked at 19 web conferencing vendors and measured their performance through in-depth interviews, analysis, and third party validation.

LogMeIn, Inc. (NASDAQ:LOGM) shares fell -0.80% in last trading session and ended the day at $50.90. LOGM Gross Margin is 86.90% and its return on assets is 3.80%. LogMeIn, Inc. (NASDAQ:LOGM) quarterly performance is -29.56%.

Leave a Reply

Your email address will not be published. Required fields are marked *